Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Kauczor (Heidelberg, Germany). Introduction on the ESR/ERS statement on low-dose lung cancer screening. International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?

Member's Comments

No comment yet.

Related content which might interest you: Update on lung cancer screening with low-dose CT Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening Year: 2021 ESR/ERS statement paper on lung cancer screening Source: Guideline 2020 Year: 2020 ESR/ERS statement paper on lung cancer screening Source: Eur Respir J, 55 (2) 1900506; 10.1183/13993003.00506-2019 Year: 2020 The evidence on CT: lung cancer screening Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice Year: 2018 Introduction: new age of lung carcinogenesis Source: Annual Congress 2008 - New age lung carcinogenesis: clinical impact Year: 2008 Factors determining early adherence to a lung cancer screening protocol Source: Eur Respir J 2007; 30: 532-537 Year: 2007 Screening for lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=71 Year: 2001 Computed tomographic screening for lung cancer: individualising the benefit of the screening Source: Eur Respir J 2007; 30: 843-847 Year: 2007 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer? Source: Eur Respir J 2003; 22: 535-541 Year: 2003 Lung cancer screening: the critical review Source: International Congress 2015 – Lung cancer screening: how to implement a comprehensive preventive approach Year: 2015 Targeted therapy for lung cancer Source: Eur Respir J 2015; 46: 1239-1241 Year: 2015 Missed lung cancer on chest radiography – does it affect the outcome? Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 Chemotherapy for small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 Update on small cell lung cancer management Source: Breathe 2012; 8: 315-330 Year: 2012 Commentary: The ERS/ESTS clinical guidelines for evaluating fitness for radical treatment for lung cancer Source: Breathe 2008; 6: 141-145 Year: 2009 Genetics and tailored treatment of lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013